Perk Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 11	Mar ' 10	Mar ' 09	Mar ' 08	Mar ' 07

Sources of funds

Owner's fund

Equity share capital

6.38

6.38

6.38

6.38

6.38

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

-0.72

-0.80

-1.13

-1.15

-0.85

Loan funds

Secured loans

0.02

0.27

0.33

0.46

0.35

Unsecured loans

-

-

-

-

-

Total

5.68

5.86

5.59

5.69

5.89

Uses of funds

Fixed assets

Gross block

4.06

4.12

6.14

6.14

6.18

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

0.14

0.14

2.02

1.87

1.71

Net block

3.92

3.98

4.12

4.27

4.47

Capital work-in-progress

-

-

-

-

-

Investments

-

-

-

-

-

Net current assets

Current assets, loans & advances

3.16

2.73

1.88

2.25

2.36

Less : current liabilities & provisions

1.40

0.85

0.42

0.85

0.99

Total net current assets

1.77

1.88

1.46

1.40

1.37

Miscellaneous expenses not written

-

-

-

0.02

0.04

Total

5.68

5.86

5.59

5.69

5.89

Notes:

Book value of unquoted investments

-

-

-

-

-

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

-

-

-

-

-

Number of equity sharesoutstanding (Lacs)

63.84

63.84

63.84

63.84

63.84